Alzheimer’s disease or a mentally-crippled condition according to a lay-man is specifically a disease leading to degeneration of neurons in the cerebral cortex which is mainly responsible for intelligence and memory. A person affected with Alzheimer’s becomes a burden on the entire family as one in a regular household implicated with a chronic disease may prove as a disturbing factor for the entirety of his caregivers. It develops at the age of about 65 leading to dementia, irritability to care giving and attacks of aggression with a wandering gait.
Alzheimer’s may be familial and sporadic with an ever-new increasing viability of the latter. However, familial instances may be progressive in individuals with specific gene mutations preferably of any one of the three major proteins linked to the formation of plaques leading to senility. These three proteins may include the amyloidal precursor protein (APP) and the presenilins 1 and 2. Sporadic causes may be initiative of the development of amyloidal plaques in the cerebral cortex leading to degeneration of the concerned neurons due to a mutation in the TREM 1 gene.
As research has made it possible to develop new drugs and techniques for the cure of various ailments, latest research has failed to provide relief for the dementia-related Alzheimer’s disease. However, Ravelesio Corporation is developing a drug which may help the patient afflicted with Alzheimer’s to respond to various modes of stress but there is no such drug which can eventually cure it.
The neurons are most specifically the only cells in the human body which are incapable of regeneration. Non-steroidal anti-inflammatory drugs (NSAIDS) have been proven to be useless in this case